The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis

被引:11
作者
Fiett, J [1 ]
Letowska, I [1 ]
Gniadkowski, M [1 ]
Hryniewicz, W [1 ]
机构
[1] Natl Inst Publ Hlth, PL-00725 Warsaw, Poland
关键词
allele identification; Bordetella pertussis; pertactin; pertussis toxin;
D O I
10.1016/S0167-7012(03)00207-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bordetella pertussis strains demonstrate polymorphism in toxin subunit S I (PT S 1) and pertactin (Prn), which belong to major protective antigens of the pathogen. Changes in the distribution of particular alleles of ptxS1 and prn genes in local B. pertussis populations have been proposed as possible factors influencing the vaccination effectiveness. We have developed a new methodology for the identification of the alleles, which eliminates the necessity of DNA sequencing. The approach is based on the evaluation of the number of sequence repeats and detection of specific nucleotides at polymorphic sites of the genes, and utilizes products of their full or partial PCR amplification. The approach is available for a laboratory with standard equipment. The total conformity of the strategy with the DNA sequencing-based approach was proved on the full set of reference strains and a group of Polish clinical isolates. The new methodology was used to investigate a collection of 120 Polish B. pertussis strains isolated from the 1960s to 2001. Similarly to findings from other countries and to earlier Polish data, the tendency to change the vaccine types of PT S1 and Prn by the antigenically different ones was observed. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:651 / 666
页数:16
相关论文
共 26 条
[1]  
Andrews R, 1997, Commun Dis Intell, V21, P145
[2]   Intranasal murine model of Bordetella pertussis infection:: II.: Sequence variation and protection induced by a tricomponent acellular vaccine [J].
Boursaux-Eude, C ;
Thiberge, S ;
Carletti, G ;
Guiso, N .
VACCINE, 1999, 17 (20-21) :2651-2660
[3]   Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999 [J].
Cassiday, P ;
Sanden, G ;
Heuvelman, K ;
Mooi, F ;
Bisgard, KM ;
Popovic, T .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1402-1408
[4]   Reemergence of pertussis in the highly vaccinated population of the Netherlands:: Observations on surveillance data [J].
de Melker, HE ;
Schellekens, JFP ;
Neppelenbroek, SE ;
Mooi, FR ;
Rümke, HC ;
Conyn-van Spaendonck, MAE .
EMERGING INFECTIOUS DISEASES, 2000, 6 (04) :348-357
[5]   Pertussis in the Netherlands: An outbreak despite high levels of immunization with whole-cell vaccine [J].
deMelker, HE ;
ConynvanSpaendonck, MAE ;
Rumke, H ;
vanWijngaarden, JK ;
Mooi, FR ;
Schellekens, JFP .
EMERGING INFECTIOUS DISEASES, 1997, 3 (02) :175-178
[6]   Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom [J].
Fry, NK ;
Neal, S ;
Harrison, TG ;
Miller, E ;
Matthews, R ;
George, RC .
INFECTION AND IMMUNITY, 2001, 69 (09) :5520-5528
[7]   Changing epidemiology of pertussis in the United States:: Increasing reported incidence among adolescents and adults, 1990-1996 [J].
Güris, D ;
Strebel, PM ;
Bardenheier, B ;
Brennan, M ;
Tachdjian, R ;
Finch, E ;
Wharton, M ;
Livengood, JR .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (06) :1230-1237
[8]   Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland [J].
Gzyl, A ;
Augustynowicz, E ;
van Loo, I ;
Slusarczyk, J .
VACCINE, 2001, 20 (3-4) :299-303
[9]  
HOEBREKX N, 2000, 41 INT C ANT AG CHEM, P279
[10]   Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity [J].
King, AJ ;
Berbers, G ;
van Oirschot, HFLM ;
Hoogerhout, P ;
Knipping, K ;
Mooi, FR .
MICROBIOLOGY-SGM, 2001, 147 :2885-2895